Neuromodulation Devices Market - Global Forecast 2026-2032

Senior executives navigating healthcare innovation require reliable, actionable analysis of the evolving landscape of therapeutic devices. The Neuromodulation Devices Market stands out for its pivotal role in enabling precision therapies across diverse neurological and clinical pathways worldwide.

Market Snapshot: Neuromodulation Devices Market Trajectory

The Neuromodulation Devices Market grew from USD 5.45 billion in 2025 to USD 5.85 billion in 2026, and is forecast to reach USD 9.13 billion by 2032 at a CAGR of 7.63%. Growth is influenced by clinical demand for targeted neurological therapies, ongoing device innovation, and strategic responses to shifting global regulations.

Scope & Segmentation

Device Modalities: Includes invasive systems such as deep brain stimulators and spinal cord stimulators, alongside noninvasive tools like transcranial magnetic stimulation and transcranial direct current stimulation.
Control Mechanisms: Covers closed-loop configurations with real-time adaptability as well as open-loop, fixed-interval systems.
Stimulation Technologies: Encompasses electrical and magnetic modalities, as well as emerging optogenetic and ultrasonic approaches under preclinical review.
Patient Demographics: Primarily targets adult and geriatric patients, with a growing focus on pediatric populations in select therapeutic centers.
Therapeutic Targets: Addresses chronic pain, movement disorders, neurological, psychiatric, urological, and gastrointestinal indications.
End-User Environments: Spans hospital operating rooms, ambulatory surgical centers, outpatient clinics, and scientific research institutions.
Distribution Channels: Integrates both traditional offline procurement and digitized direct-to-customer pathways, reflecting changing stakeholder preferences.
Geographic Regions: Focuses on Americas, EMEA (Europe, Middle East, Africa), and Asia-Pacific, each exhibiting distinct growth and regulatory dynamics.

Key Takeaways

Precision neuromodulation techniques are enabling care personalization, especially as patients and clinicians seek alternatives to conventional pharmacological therapies.
Continued advances in both invasive and noninvasive device design are expanding clinical applicability, with miniaturization and integrated imaging enhancing procedural and post-implantation workflows.
Collaboration between device developers, digital health platforms, and academic institutions is accelerating through the incorporation of artificial intelligence for parameter optimization and patient monitoring.
The aging global population is increasing the burden of chronic and degenerative neurological conditions, driving demand for neuromodulation interventions across regions.
Multifunctional, adaptive closed-loop networks are progressively shaping the market, aligning with the direction of precision medicine and continuous patient feedback.

Tariff Impact: Supply Chain and Cost Structures in 2025

Recent United States tariff implementations on specialized components, such as electrodes and control units, are directly influencing the production costs and procurement strategies for neuromodulation device manufacturers. Companies are adapting their sourcing by dual-sourcing in Southeast Asia and Eastern Europe and enhancing domestic fabrication. These shifts impact payer negotiations, leading to a growing exploration of value-based contract models that emphasize long-term efficacy over unit pricing. Downstream, healthcare providers increasingly consider noninvasive digital solutions to optimize workflow efficiency amid tariff-induced cost pressures.

Methodology & Data Sources

This report adopts a rigorous blend of qualitative and quantitative research. Methodologies include in-depth interviews with neurology and regulatory experts, reviews of peer-reviewed literature, triangulation through proprietary datasets, and multiple rounds of validation by subject-matter authorities.

Why This Report Matters

Enables strategic decision-making by mapping actionable opportunities in device innovation, regional approaches, and clinical care pathways.
Delivers clarity on regulatory and reimbursement influences so leaders can anticipate policy shifts and market access barriers.
Highlights technology convergence and supply chain strategies relevant for resilient, growth-oriented enterprises.

Conclusion

The neuromodulation sector is marked by continuous technological development, policy evolution, and rising demand for patient-centered care. Stakeholders able to integrate cross-sector partnerships and adaptive supply strategies are well-placed to capture future opportunities in advanced neurological therapies.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Neuromodulation Devices Market, by Device Type

8.1. Invasive Devices
8.1.1. Deep Brain Stimulators
8.1.2. Sacral Nerve Stimulators
8.1.3. Spinal Cord Stimulators
8.1.4. Vagus Nerve Stimulators
8.2. Noninvasive Devices
8.2.1. Transcranial Direct Current Stimulation
8.2.2. Transcranial Magnetic Stimulation

9. Neuromodulation Devices Market, by Control Mechanism

9.1. Closed Loop
9.2. Open Loop

10. Neuromodulation Devices Market, by Technology

10.1. Electrical Stimulation
10.2. Magnetic Stimulation
10.3. Optogenetic Stimulation
10.4. Ultrasonic Stimulation

11. Neuromodulation Devices Market, by Age Group

11.1. Adult
11.2. Geriatric
11.3. Pediatric

12. Neuromodulation Devices Market, by Therapeutic Area

12.1. Gastrointestinal & Urological Disorders
12.2. Neurological Disorders
12.2.1. Dystonia
12.2.2. Epilepsy
12.2.3. Parkinson’s Disease
12.3. Pain Management
12.3.1. Chronic Pain
12.3.2. Neuropathic Pain
12.4. Psychiatric Disorders
12.4.1. Depression
12.4.2. Obsessive-Compulsive Disorder

13. Neuromodulation Devices Market, by End User

13.1. Ambulatory Surgical Centers
13.2. Clinics
13.3. Hospitals
13.4. Research Institutes

14. Neuromodulation Devices Market, by Distribution Channel

14.1. Offline
14.2. Online

15. Neuromodulation Devices Market, by Region

15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific

16. Neuromodulation Devices Market, by Group

16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO

17. Neuromodulation Devices Market, by Country

17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea

18. United States Neuromodulation Devices Market
19. China Neuromodulation Devices Market

20. Competitive Landscape

20.1. Market Concentration Analysis, 2025
20.1.1. Concentration Ratio (CR)
20.1.2. Herfindahl Hirschman Index (HHI)
20.2. Recent Developments & Impact Analysis, 2025
20.3. Product Portfolio Analysis, 2025
20.4. Benchmarking Analysis, 2025
20.5. Abbott Laboratories
20.6. Aleva Neurotherapeutics SA
20.7. Biotronik SE & Co. KG
20.8. Boston Scientific Corporation
20.9. BrainsWay Ltd.
20.10. ElectroCore, Inc.
20.11. Integer Holdings Corporation
20.12. Laborie
20.13. Life Science Outsourcing, Inc.
20.14. LivaNova PLC
20.15. Medtronic plc
20.16. Neuromod Devices Limited
20.17. Neuronetics, Inc.
20.18. Neuropace Inc.
20.19. NeuroSigma, Inc.
20.20. Nexstim Oyj
20.21. Saluda Medical Pty Ltd
20.22. Soterix Medical Inc.
20.23. Synapse Biomedical Inc.
20.24. Synergia Medical SA
20.25. tVNS Technologies GmbH

List of Figures

FIGURE 1. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL NEUROMODULATION DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL NEUROMODULATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 15. CHINA NEUROMODULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SACRAL NERVE STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY VAGUS NERVE STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CLOSED LOOP, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CLOSED LOOP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CLOSED LOOP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OPEN LOOP, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OPEN LOOP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OPEN LOOP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY MAGNETIC STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY MAGNETIC STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY MAGNETIC STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OPTOGENETIC STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OPTOGENETIC STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OPTOGENETIC STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ULTRASONIC STIMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ULTRASONIC STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ULTRASONIC STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY GASTROINTESTINAL & UROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY GASTROINTESTINAL & UROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY GASTROINTESTINAL & UROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DYSTONIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DYSTONIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DYSTONIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PARKINSON’S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PARKINSON’S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROPATHIC PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY NEUROPATHIC PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEPRESSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEPRESSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DEPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OBSESSIVE-COMPULSIVE DISORDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OBSESSIVE-COMPULSIVE DISORDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OBSESSIVE-COMPULSIVE DISORDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 169. EUROPE NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. EUROPE NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 171. EUROPE NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 172. EUROPE NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 173. EUROPE NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 174. EUROPE NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 175. EUROPE NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 176. EUROPE NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 177. EUROPE NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 178. EUROPE NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 179. EUROPE NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 180. EUROPE NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 181. EUROPE NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 195. AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 197. AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 198. AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 199. AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 200. AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 201. AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 202. AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 203. AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 204. AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 205. AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 206. AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. AFRICA NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 210. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 222. ASEAN NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. ASEAN NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 224. ASEAN NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 225. ASEAN NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 226. ASEAN NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 227. ASEAN NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 228. ASEAN NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 229. ASEAN NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 230. ASEAN NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 231. ASEAN NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 232. ASEAN NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 233. ASEAN NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. ASEAN NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 235. GCC NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 236. GCC NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 237. GCC NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 238. GCC NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 239. GCC NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 240. GCC NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 241. GCC NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 242. GCC NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 243. GCC NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 244. GCC NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 245. GCC NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 246. GCC NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. GCC NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 248. EUROPEAN UNION NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. BRICS NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. BRICS NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 263. BRICS NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 264. BRICS NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 265. BRICS NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 266. BRICS NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 267. BRICS NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 268. BRICS NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 269. BRICS NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 270. BRICS NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 271. BRICS NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 272. BRICS NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 273. BRICS NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 274. G7 NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 275. G7 NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 276. G7 NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 277. G7 NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 278. G7 NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 279. G7 NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 280. G7 NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 281. G7 NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 282. G7 NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 283. G7 NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 284. G7 NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 285. G7 NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 286. G7 NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 287. NATO NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 288. NATO NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 289. NATO NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 290. NATO NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 291. NATO NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 292. NATO NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 293. NATO NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 294. NATO NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 295. NATO NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 296. NATO NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 297. NATO NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 298. NATO NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 299. NATO NEUROMODULATION DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 300. GLOBAL NEUROMODULATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 301. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 302. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 303. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY INVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 304. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY NONINVASIVE DEVICES, 2018-2032 (USD MILLION)
TABLE 305. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY CONTROL MECHANISM, 2018-2032 (USD MILLION)
TABLE 306. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 307. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
TABLE 308. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 309. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 310. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 311. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY PSYCHIATRIC DISORDERS, 2018-2032 (USD MILLION)
TABLE 312. UNITED STATES NEUROMODULATION DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 313. UNITED

Companies Mentioned

The key companies profiled in this Neuromodulation Devices market report include:

Abbott Laboratories
Aleva Neurotherapeutics SA
Biotronik SE & Co. KG
Boston Scientific Corporation
BrainsWay Ltd.
ElectroCore, Inc.
Integer Holdings Corporation
Laborie
Life Science Outsourcing, Inc.
LivaNova PLC
Medtronic plc
Neuromod Devices Limited
Neuronetics, Inc.
Neuropace Inc.
NeuroSigma, Inc.
Nexstim Oyj
Saluda Medical Pty Ltd
Soterix Medical Inc.
Synapse Biomedical Inc.
Synergia Medical SA
tVNS Technologies GmbH

Table Information

Report Attribute	Details
No. of Pages	189
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 5.85 Billion
Forecasted Market Value ( USD ) by 2032	$ 9.13 Billion
Compound Annual Growth Rate	7.6%
Regions Covered	Global
No. of Companies Mentioned	22

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Neuromodulation Devices Market Trajectory

Scope & Segmentation

Key Takeaways

Tariff Impact: Supply Chain and Cost Structures in 2025

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Neuromodulation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

Internal Neuromodulation Devices Market Report 2025

Neuromodulation Market - Global Forecast 2026-2032

Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2025-2033

Neuromodulation Market by Technology, Stimulation Type, Application, End User, and Region - Global Forecast to 2030